CheckMan Stock Market Overview

NEW YORK, June 8, 2026 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces the Company has arranged a $975 million balance sheet financing for Project Helios, a newly constructed, state-of-the-art data center in Northern Virginia, a critical hub for internet traffic and network infrastructure. Newmark Co-Head of Global Debt & Structured Finance Jordan Roeschlaub, Vice Chairman Christopher Kramer, Managing Directors Chris Lozinak and John Caraviello and Associate Director Ryan Bub, alongside sector specialists Andrew Warin, Head of Strategic Advisory, and Phil O'Bannon, Head of Infrastructure, represented the borrower, a joint venture between Affinius Capital and Corscale Data Centers.

Modine lands a long-term AI data center cooling deal targeting $4B+ sales in 2027-29, backed by a $165M upfront payment to expand capacity.

ABBV climbs 12% a month as investors weigh the raised 2026 guidance, Skyrizi and Rinvoq growth, and multiple pipeline updates.

In oil-driven volatility, brokers favor ALTO, ARW, GPRE, AAL and ACDVF. These are screened for upgrades, estimate lifts and low P/S.

Stoke Therapeutics, Inc. (STOK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update Transcript

Adobe Inc (NASDAQ:ADBE) is set to report fiscal second-quarter earnings after the close on Thursday, June 11.

Investors need to pay close attention to MMSI stock based on the movements in the options market lately.

I rate ProShares Ultra Bloomberg Natural Gas ETF and its bearish counterpart KOLD a Buy as tactical trading tools amid heightened volatility. U.S. natural gas prices pivot around $3/MMBtu, with volatility driven by global LNG demand and geopolitical risks in Europe and the Middle East. BOIL and KOLD are suitable only for short-term risk positions due to leverage, time decay, and high management fees; strict risk management is essential.

Altimmune is betting on pemvidutide across MASH and alcohol-related liver diseases, with key 2026 data and a planned Phase III launch shaping its path.